DRACP04067 |
Tat (47鈥?7)-Arenicin-3 [G1,12A; Y5N; Y17H], T11N2 |
YGRKKRRQRRRAFCWNVCVYRNAVRVCHRRCN |
32 |
Synthetic |
DRACP04068 |
|
DILIIVGGKERKKRRR |
16 |
Synthetic |
DRACP04069 |
|
DILIIVGGGSGKERKKRRR |
19 |
Synthetic |
DRACP04070 |
|
DILIIVGGKRRR |
12 |
Synthetic |
DRACP04071 |
|
DILIIVGGRRRR |
12 |
Synthetic |
DRACP04072 |
|
DGRCLLIIKLAKLAKKLAKLAK |
22 |
Synthetic |
DRACP04073 |
Myotoxin II (105-117)[Y3,6W][Y5K,P9W,C11A], PEM-2 [W5K,A9W] |
KKWRKWLKWLAKK |
13 |
Synthetic |
DRACP04074 |
Aurein-2.2 (1-14)[V10L, G11K, A12L, G14K] |
GLFDIVKKVLKLLK |
14 |
Synthetic |
DRACP04075 |
Polymyxin CAMP113 |
XTXCXfXRXc |
10 |
Synthetic |
DRACP04076 |
Polymyxin CAMP207 |
XTXCXxXXXc |
10 |
Synthetic |
DRACP04077 |
|
CASYFCRWWWRR |
12 |
Synthetic |
DRACP04078 |
|
CASYFCRWWWAA |
12 |
Synthetic |
DRACP04079 |
|
CASYFCRWWWLL |
12 |
Synthetic |
DRACP04080 |
|
CASYFC |
6 |
Synthetic |
DRACP04081 |
|
RWWWLL |
6 |
Synthetic |
DRACP04082 |
|
RWWWAA |
6 |
Synthetic |
DRACP04083 |
|
EKKRLLKWWR |
10 |
Synthetic |
DRACP04084 |
|
KWWKLLRKKR |
10 |
Synthetic |
DRACP04085 |
Mastoparan-like peptide 12d |
INLKAIAAMAKKLL |
14 |
Animalia |
DRACP04086 |
Temporin-AL-d, Amolopin-2e |
FLPIAGKLLSGLSGLL |
16 |
Animalia |
DRACP04087 |
Oncocin (1-11)-MDAP-2 (28-35)[Q19R], OM19R |
VDKPPYLPRPRPIRRPGGR |
19 |
Synthetic |
DRACP04088 |
Oncocin (1-11)-MDAP-2 (28-35)[R15r,Q19r] |
VDKPPYLPRPRPIRrPGGr |
19 |
Synthetic |
DRACP04089 |
MBD-4 (11-40) / P9 [H21R,K23R,K28R], P9R |
NGAICWGPCPTAFRQIGNCGRFRVRCCRIR |
30 |
Synthetic |
DRACP04090 |
Phylloseptin-PV1, PPV1 |
FLSLIPKIAGGIAALVKNL |
19 |
Animalia |
DRACP04091 |
MDAP-2 [Q35R] |
SRDSRPVQPRVQPPPPPPKQKPSIYDTPIRRPGGRKTMYA |
40 |
Synthetic |
DRACP04092 |
PN-CATH1 |
KKCNFFCKLKKKVKSVGSRNLIGSATHHHRIYRV |
34 |
Animalia |
DRACP04093 |
PN-CATH2 |
EGCNILCLLKRKVKAVKNVVKNVVKSVVG |
29 |
Animalia |
DRACP04094 |
RTH-sh-Buforin |
RTHRAGLQFPVGRVHRLLRK |
20 |
Synthetic |
DRACP04095 |
D-sh-Buforin |
raGlqfpvGrvhrllrk |
17 |
Synthetic |
DRACP04096 |
D-RTH-D-sh-Buforin |
rthraGlqfpvGrvhrllrk |
20 |
Synthetic |